Most founders would rather sell to their own people. The clients stay, the culture survives, nobody rebrands the office, and the person who has run your best department for nine years gets the thing they have quietly wanted for five of them.
Then the same objection arrives every time: they haven't got the money. Which is true, and entirely beside the point. Almost nobody who buys a business has the money. What matters is whether the business can pay for itself.
A practice buy-out is funded from three places, and they behave very differently.
Management equity. Cash from the buying team, usually raised against houses or savings. It is almost always the smallest slice, and its purpose is commitment rather than quantum. A lender and a seller both want the incoming owners to have something at stake that they would genuinely mind losing.
Third-party debt. Borrowed by the acquiring company against the target's own cash generation. Professional services firms borrow reasonably well because the revenue is recurring and the client attrition is measurable, but a lender is sizing the loan against maintainable profit, not against the fee book.
Vendor finance. The part of the price the seller agrees to receive later, typically as a loan to the buying company repaid over three to five years. In most practice deals this is the largest single component, which is the sentence founders tend to read twice.
Take an illustrative practice with £1.4m of gross recurring fees, valued at 1.1 times fees — £1.54m. Three managers want to buy it. Our note on how accountancy practices are valued explains where a multiple like that comes from.
The founder receives £750,000 at completion, or 48.7% of the price. A consolidator paying 60% up front on the same valuation would have handed over £924,000. So on day one the internal sale is £174,000 lighter, and the balance depends on a business the founder no longer runs.
Now test whether it works. Assume the practice generates £350,000 of adjusted profit — 25% of fees — after paying the three incoming owners proper market salaries. That adjustment matters enormously and is the one founders resist, because a firm where the owner takes a small salary and large dividends looks far more profitable than the same firm run by employed managers.
Against that £350,000:
Which is not a deal. It is a business with £3,040 of annual headroom, no capacity for a bad year, no money for investment, and three new owners who have signed personal guarantees for the privilege. One client loss or one hire and it is underwater.
The number that has to move is rarely the valuation. Four levers do more work:
Vendor finance makes the founder an unsecured creditor of a company they no longer control, ranking behind the bank. That position is manageable, but only if it is documented while you still have leverage — which is before completion, not after.
Security over the shares or assets. Personal guarantees from the buying team, capped and specific. Restrictions on dividends, salary increases and capital spending while the deferred amount is outstanding. Information rights, so you see monthly management accounts rather than finding out at the year end. And a step-in right if payments are missed, which almost nobody ever uses but which changes every conversation that happens before it would be needed.
The tax treatment of deferred consideration also differs materially depending on how it is structured, and it is decided at the drafting stage rather than when the money arrives. Our note on tax when you sell your practice sets out the moving parts.
An internal sale usually pays less at completion and carries more risk for longer. In exchange it tends to preserve the fee base, avoid the staff attrition that erodes deferred consideration in external deals, involve lighter diligence, and leave behind a firm the founder is still content to be associated with.
Neither route is better in the abstract. What decides it is whether your management team genuinely wants ownership, and whether the profit can carry the price. Both of those are answerable eighteen months out, and neither is answerable in the fortnight after somebody makes you an offer. Our note on succession options for firm founders compares the routes side by side.
They do not buy it out of savings. A management buy-out is funded from three sources stacked together: a modest amount of personal equity from the buying team, third-party debt raised against the firm's own cash generation, and deferred consideration left in by the seller. The team's own money is usually the smallest slice by some distance, and its purpose is commitment rather than quantum. What actually pays for the firm is the firm, over several years, out of the profits it goes on to make. That is why maintainable profit rather than headline value decides whether the deal is possible.
Usually less on day one, and not always less in total. A trade or consolidator buyer typically pays a larger proportion at completion because it has balance sheet behind it. A management team pays a smaller proportion at completion and more over time, so the seller carries more of the risk for longer. Against that, an internal sale often preserves more of the fee base, involves lighter diligence, avoids a rebrand and rarely triggers the staff departures that erode deferred consideration in an external deal. Compare the two on cash actually received, not on headline price.
Vendor finance is simply the part of the price you agree to be paid later, usually as a loan from you to the buying company, repaid in instalments with or without interest. It is the largest single component of most practice buy-outs. The risk is real: you are an unsecured creditor of a business you no longer control, ranking behind the bank. Sellers reduce that risk with security over the shares or assets, a personal guarantee from the buying team, restrictions on dividends and salaries while the debt is outstanding, and a step-in right if payments are missed.
Expect six to twelve months from first serious conversation to completion, and longer if the management team has to be built before it can buy. Diligence is lighter than an external sale because the buyers already know the firm, but funding takes time: a lender will want two or three years of accounts, a business plan owned by the incoming team rather than by you, and evidence that the fee base survives your departure. The part that most often adds months is not the paperwork but the team deciding whether it genuinely wants to own something.
Arithmetic, followed by nerve. The firm has to generate enough profit, after paying the incoming owners a proper market salary, to service the bank debt and the deferred consideration at the same time. Where a founder has been taking a modest salary and large dividends, that adjustment alone can remove most of the apparent profit and make the price unaffordable. The second cause is a management team that wants the title without the personal guarantee. Both problems are visible eighteen months out, which is when the conversation should start.
All figures in this article are illustrative and chosen to show the arithmetic clearly. The 1.1 times fees valuation, the 9% cost of borrowing and the 25% adjusted margin are assumptions used for the worked example, not quotations, market averages or terms available from any lender. Your own firm's numbers will differ.
This article is general information about how management buy-outs of professional services firms are structured and funded, not legal, tax, financial or investment advice, and Founder Capital LLP is not authorised or regulated by the Financial Conduct Authority. Nothing here is an offer or invitation to invest; any investment opportunities we reference are available only to professional investors, certified high-net-worth individuals and self-certified sophisticated investors, are not open to retail investors, and capital is at risk and returns are not guaranteed. Please take specific advice from a corporate finance adviser and a solicitor before you act.
